This multinational and multidisciplinary meeting offers a distinct opportunity for professionals from various fields to share their knowledge and collaborate on cutting-edge research in paediatric haemato-oncology.
The programme includes novel session formats, interactive workshops and forums in order to empower clinical trial groups to debate and disseminate the outcomes of the high quality clinical and basic research carried out in Europe.
Since scientific research takes place in silos, there is a need to bridge these worlds by bringing together the whole spectrum of scientists, thinkers and key opinion leaders interested in addressing the main challenges faced in this field. An innovative focus will be on direct interaction between tumour and clinical trial groups, parent groups, and survivors to spur innovative therapies against childhood cancer.
The programme for Wednesday 22 May is dedicated to best practice and educational sessions on cross-tumour topics (including debates and keynote lectures).